| AXOGEN INC. DL -,01 |
| USA |
| Gesundheit |
| US05463X1063 / A1JMHK |
| LT3 (Frankfurt) / AXGN (NASDAQ) |
| FRA:LT3, ETR:LT3, LT3:GR, NASDAQ:AXGN |
| - |
| https://www.axogeninc.com.. |
|
Axogen Inc. is a leading developer and marketer of innovative surgical solutions for peripheral nerve regeneration and repair. The company specializes in biologically active technologies, including the Avance Nerve Graft, an off-the-shelf processed h..
>Volltext.. |
| 1405.4 Mio. EUR |
| 1424.05 Mio. EUR |
| 194.72 Mio. EUR |
| 0.57 Mio. EUR |
| -13.58 Mio. EUR |
| -0.29 EUR |
| 58.47 Mio. EUR |
| 34.19 Mio. EUR |
| 0.7 Mio. EUR |
| 1.93 |
| 5.96% |
| -38.91% |
| - |
| - |
| - |
| AXOGEN |
| 02.04.26 |
|